A few years ago, Harvey Fineberg, MD, PhD, then president of the Institute of Medicine, developed his own set of 7 deadly sins for public health (1). Of the original 7 sins, he kept sloth, greed, and gluttony, but he added ignorance, complacency, timidity, and obstinacy to round out his public health mix. His sins and corresponding definitions tended to focus primarily on the broader public-for example, he noted that sloth blocks people from doing daily activities that would keep them healthy and gluttony keeps people eating when they are no longer hungry. However, I suspect his choice of "sins" could also apply to health care providers, companies in the health care market, policymakers, and other public health stakeholders.
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In this first of a 2-part Leadership Page series on these 7 deadly sins, I want to focus on greed, complacency, timidity, and obstinacy: the challenges they pose to public health and what is being done to overcome them.
Greed by definition is "a selfish desire to have more of something" (2). For a very small minority of physicians, greed can lead to excessive testing and procedures to increase their bottom line. With public distribution of annual Medicare billing and payment records and whistleblower suits, much attention has been brought to these physicians. Similarly, some institutions have been "called out" for excessive payments to high-level management or have been accused of treating insured patients differently from those who are uninsured or on Medicare or Medicaid.
The pharmaceutical, health insurance, and device industries are also not immune from greed, whether it is disproportionate chief executive officer salaries, high costs of drugs-particularly generic drugs recently-or the rush to get drugs or devices to market on the basis of research derived from data that is subsequently identified as flawed.
Although greed does not characterize the majority in any of these situations, everyone is affected when cases of greed become the focus of the media, policymakers, and/or the public. There are many examples of the "sins of a few" resulting in "shackling of the masses," with both ethics and quality of care of physicians, for example, being often questioned and never assumed. On a broad scale, some of this culture of suspicion has led to the ongoing evolution from a volume-focused to a value-focused health care system. This transformation will make it more difficult for providers and institutions to financially benefit from unwarranted tests and procedures. Additionally, with a significant number of Americans receiving health insurance as a result of the Affordable Care Act, it is more difficult for hospitals to "cherry-pick" Williams, Sr. Reaching consensus around these changes was a 2-year process that required everyone involved to put aside greed, complacency, timidity, and obstinacy.
The resulting structure and process, although clearly a work in progress, is a testament to each and every president@acc.org.
